Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

2.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.

3.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS.

N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.

4.

The association between meteorological variables and the abundance of Aedes taeniorhynchus in the Florida Keys.

Hribar LJ, DeMay DJ, Lund UJ.

J Vector Ecol. 2010 Dec;35(2):339-46. doi: 10.1111/j.1948-7134.2010.00092.x.

5.

Desensitization and heart transplantation of a patient with high levels of donor-reactive anti-human leukocyte antigen antibodies.

Bućin D, Gustafsson R, Ekmehag B, Kornhall B, Algotsson L, Lund U, Otto G, Koul B.

Transplantation. 2010 Dec 15;90(11):1220-5. doi: 10.1097/TP.0b013e3181fa93c6.

PMID:
20885338
6.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group.

N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. Erratum in: N Engl J Med. 2010 Apr 15;362(15):1450.

PMID:
19332456
7.

Perinatal events and the risk of developing primary sclerosing cholangitis.

Bergquist A, Montgomery SM, Lund U, Ekbom A, Olsson R, Lindgren S, Prytz H, Hultcrantz R, Broomé U.

World J Gastroenterol. 2006 Oct 7;12(37):6037-40.

8.

A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia.

Galanello R, Kattamis A, Piga A, Fischer R, Leoni G, Ladis V, Voi V, Lund U, Tricta F.

Haematologica. 2006 Sep;91(9):1241-3.

9.

Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.

Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Nielsen P.

Ann N Y Acad Sci. 2005;1054:429-32.

PMID:
16339692
10.
11.

Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys.

Lund U, Rippe A, Venturoli D, Tenstad O, Grubb A, Rippe B.

Am J Physiol Renal Physiol. 2003 Jun;284(6):F1226-34. Epub 2003 Mar 4.

12.

Microcalorimetric evaluation of blood compatibility of hemodialysis membranes.

Ikomi-Kumm J, Ljunggren L, Lund U, Monti M, Thysell H.

Blood Purif. 1991;9(4):177-81.

PMID:
1818580
14.
15.

Supplemental Content

Loading ...
Support Center